Peter de Keizer, Senolytics, and the FOXO4-DRI Connection
Peter de Keizer's work on selective senescent-cell elimination via FOXO4-DRI connects him to the senolytic intervention class, as described in the paper 'Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis'.
Peter de Keizer is an associate professor at UMC Utrecht and founder of Cleara Biotech. His group studies the heterogeneity of senescent cells and develops approaches to eliminate their harmful effects in aging and cancer. One such approach is FOXO4-DRI, aimed at the selective elimination of senescent cells. The paper "Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis" describes this line of work.
FOXO4-DRI is what connects de Keizer to senolytics, a class of interventions designed to selectively eliminate senescent cells while sparing non-senescent cells. FOXO4-DRI is described as a tool for such selective elimination. The available evidence does not address the clinical efficacy of FOXO4-DRI.
The edge is grounded in a named paper and a specific named approach (FOXO4-DRI), making it possible to explain a concrete research connection without speculation. The senolytics term definition and de Keizer's biography together support a coherent, fact-bounded dispatch.